Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;7(3):34-40.

Adverse effect of high glucose concentration on stem cell therapy

Affiliations
Review

Adverse effect of high glucose concentration on stem cell therapy

Najmaldin Saki et al. Int J Hematol Oncol Stem Cell Res. 2013.

Abstract

Stem cell therapy could have great potential for the treatment of a wide variety of diseases. Stem cells might have the ability to differentiate into a widespread cell types, and to repopulate and revitalize the damaged cells with healthy tissue, and improve its performance. We provide here the evidence supporting the critical use of stem cell as a treatment in disease conditions existing with high glucose complaint such as diabetes. The reduction of glucose stimulated cell proliferation and high glucose enhanced apoptosis in rat model, which may be a problem in therapeutic strategies based on ex vivo expansion of stem cell, and may also propagate the development of osteoporosis in high glucose complaint such as diabetes. This leads to the hypothesis that, high glucose could be more deleterious to stem cell therapy that may be due to the aggravation of oxidative stress triggered by high glucose. These findings may help to understand the possible reasons associated with high glucose induced detrimental effects on stem cells as well as provide novel therapeutic strategies for preventing the adverse effects of glucose on the development and progression of stem cells in patients with diabetes.

Keywords: Differentiation; Glucose; Proliferation; Regulation; Stem cell therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Adverse effects of high glucose on stem cell therapy Abbreviations: SC, Stem cell; AT1, ANG II type 1; BMP2, Bone morphogenic protein; CDK, Cyclin dependent kinase; ROS, Reactive oxidative stress; PKC, Protein kinase C; Cbfa1, Core binding factor alpha-1

References

    1. Larijani B, et al. Stem cell therapy in treatment of different diseases. Acta Med Iran. 2012;50(2):79–96. - PubMed
    1. Brehm M, Stanske B, Strauer B.E. Therapeutic potential of stem cells in elderly patients with cardiovascular disease. Exp Gerontol. 2008;43(11):1024–32. - PubMed
    1. Hassiotou F, et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells. 2012;30(10):2164–74. - PMC - PubMed
    1. Ding V, Choo A.B, Oh S.K. Deciphering the importance of three key media components in human embryonic stem cell cultures. Biotechnol Lett. 2006;28(7):491–5. - PubMed
    1. Scheepers A, Joost H.G, Schurmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr. 2004;28(5):364–71. - PubMed

LinkOut - more resources